Nanomedicine News RSS Feed - Nanomedicine

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides, Inc. celebrated the grand opening of its new R&D and cGMP pilot manufacturing facility with Congressman Jim Himes as the Chief Guest yesterday, July 21. [More]
DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

Since they were first developed a quarter-century ago, carbon nanotubes (CNTs) have impressed scientists with their mechanical strength and stiffness, their optical performance, and their ability to conduct heat and electricity. [More]
New Material Holds Potential for Development of New Formulations of Rejected Drugs

New Material Holds Potential for Development of New Formulations of Rejected Drugs

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. [More]
Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

If you’re allergic to dust mites (and chances are you are), help may be on the way. [More]
Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced an update on the TKM-Ebola Phase I clinical hold. The Company has received the clinical hold letter from the U.S. Food and Drug Administration (FDA) and is preparing a Complete Response to the Agency. The Company anticipates this matter will be resolved by Q4, 2014. [More]
Celator Broadens Application of CombiPlex Platform and CPX-351 for AML Treatment

Celator Broadens Application of CombiPlex Platform and CPX-351 for AML Treatment

Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today will present updates on its lead candidate CPX-351 and CombiPlex® technology platform at its Analyst Day meeting for analysts and investors. [More]
Researchers Employ Magnetized Carbon Nanotubes to Extract Biomolecules from Live Cells

Researchers Employ Magnetized Carbon Nanotubes to Extract Biomolecules from Live Cells

University of Houston researchers have devised a new method for extracting molecules from live cells without disrupting cell development, work that could provide new avenues for the diagnosis of cancer and other diseases. [More]
Improved Method for Exact Dosing of Heavy Ion Irradiation to Treat Cancer

Improved Method for Exact Dosing of Heavy Ion Irradiation to Treat Cancer

PTB has developed a method for the more exact dosing of heavy ion irradiation in the case of cancer [More]
New Self-Assembling Nanoparticle Enables Early Diagnosis of Cancer

New Self-Assembling Nanoparticle Enables Early Diagnosis of Cancer

Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier. [More]
NanoViricides Presents FluCide Data at 3rd Annual Influenza Research and Development Conference

NanoViricides Presents FluCide Data at 3rd Annual Influenza Research and Development Conference

NanoViricides, Inc. reports that its President, Dr. Anil Diwan, was invited to present the FluCide™ data at the 3rd Annual Influenza Research and Development Conference on Friday, July 11, at 0850 am. [More]